150 related articles for article (PubMed ID: 28881312)
21. Impact of metal coordination on cytotoxicity of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine) and novel insights into terminal dimethylation.
Kowol CR; Trondl R; Heffeter P; Arion VB; Jakupec MA; Roller A; Galanski MS; Berger W; Keppler BK
J Med Chem; 2009 Aug; 52(16):5032-43. PubMed ID: 19637923
[TBL] [Abstract][Full Text] [Related]
22. Phase I and pharmacokinetic study of Triapine, a potent ribonucleotide reductase inhibitor, in adults with advanced hematologic malignancies.
Gojo I; Tidwell ML; Greer J; Takebe N; Seiter K; Pochron MF; Johnson B; Sznol M; Karp JE
Leuk Res; 2007 Sep; 31(9):1165-73. PubMed ID: 17324462
[TBL] [Abstract][Full Text] [Related]
23. A Ferrous-Triapine complex mediates formation of reactive oxygen species that inactivate human ribonucleotide reductase.
Shao J; Zhou B; Di Bilio AJ; Zhu L; Wang T; Qi C; Shih J; Yen Y
Mol Cancer Ther; 2006 Mar; 5(3):586-92. PubMed ID: 16546972
[TBL] [Abstract][Full Text] [Related]
24. Liquid chromatography-tandem mass spectrometric assay for the multikinase inhibitor regorafenib in plasma.
Luethi D; Durmus S; Schinkel AH; Schellens JH; Beijnen JH; Sparidans RW
Biomed Chromatogr; 2014 Oct; 28(10):1366-70. PubMed ID: 24619951
[TBL] [Abstract][Full Text] [Related]
25. Development and validation of a sensitive LC-MS/MS assay for simultaneous quantitation of ranolazine and its three metabolites in human plasma.
Wang Y; Chen X; Sun Z; Yang Y; Zhang Y; Liu W; Zhong D
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Mar; 889-890():10-6. PubMed ID: 22377406
[TBL] [Abstract][Full Text] [Related]
26. Liquid chromatography-tandem mass spectrometric assay for the ALK inhibitor crizotinib in mouse plasma.
Sparidans RW; Tang SC; Nguyen LN; Schinkel AH; Schellens JH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Sep; 905():150-4. PubMed ID: 22940474
[TBL] [Abstract][Full Text] [Related]
27. Quantitation of iohexol, a glomerular filtration marker, in human plasma by LC-MS/MS.
Holleran JL; Parise RA; Guo J; Kiesel BF; Taylor SE; Ivy SP; Chu E; Beumer JH
J Pharm Biomed Anal; 2020 Sep; 189():113464. PubMed ID: 32659569
[TBL] [Abstract][Full Text] [Related]
28. Quantitation of Cabozantinib in Human Plasma by LC-MS/MS.
Jones R; Holleran J; Parise RA; Rudek MA; Chan J; Wen Y; Gobburu J; Lewis LD; Beumer JH
J Chromatogr Sci; 2022 Mar; 60(3):274-279. PubMed ID: 34240176
[TBL] [Abstract][Full Text] [Related]
29. Development and validation of LC-MS/MS method for simultaneous determination of sofosbuvir and daclatasvir in human Plasma: Application to pharmacokinetic study.
Abdallah OM; Abdel-Megied AM; Gouda AS
Biomed Chromatogr; 2018 Jun; 32(6):e4186. PubMed ID: 29314090
[TBL] [Abstract][Full Text] [Related]
30. Development and validation of sensitive and selective LC-MS/MS methods for the determination of BMS-708163, a gamma-secretase inhibitor, in plasma and cerebrospinal fluid using deprotonated or formate adduct ions as precursor ions.
Gu H; Deng Y; Wang J; Aubry AF; Arnold ME
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Sep; 878(25):2319-26. PubMed ID: 20674522
[TBL] [Abstract][Full Text] [Related]
31.
Safiarian MS; Watson RA; Lieberman RL; Barry BA; Offenbacher AR
J Phys Chem Lett; 2021 Sep; 12(37):9020-9025. PubMed ID: 34516127
[TBL] [Abstract][Full Text] [Related]
32. Liquid chromatography-tandem mass spectrometric assay for eltrombopag in 50μL of human plasma: a pharmacokinetic study.
Maddela R; Gajula R; Pilli NR; Siddiraju S; Maddela S; Makula A
J Pharm Biomed Anal; 2014 Sep; 98():68-73. PubMed ID: 24887483
[TBL] [Abstract][Full Text] [Related]
33. LC-MS/MS determination of 2-(4-((2-(2S,5R)-2-Cyano-5-ethynyl-1-pyrrolidinyl)-2-oxoethylamino)-4-methyl-1-piperidinyl)-4-pyridinecarboxylic acid (ABT-279) in dog plasma with high-throughput protein precipitation sample preparation.
Kim J; Flick J; Reimer MT; Rodila R; Wang PG; Zhang J; Ji QC; El-Shourbagy TA
Biomed Chromatogr; 2007 Nov; 21(11):1118-26. PubMed ID: 17590862
[TBL] [Abstract][Full Text] [Related]
34. Validation of an LC-ESI-MS/MS method for the determination of apalutamide, a novel non-steroidal anti-androgen in mice plasma and its application to a pharmacokinetic study in mice.
Hallur G; Purra BR; Sulochana SP; Saini NK; Daram P; Zainuddin M; Mullangi R
J Pharm Biomed Anal; 2018 May; 153():260-266. PubMed ID: 29518645
[TBL] [Abstract][Full Text] [Related]
35. Simultaneous determination of a p38 MAP kinase inhibitor and its amide hydrolyzed metabolite in Cynomolgus monkey plasma by LC-MS/MS, and its application to a toxicokinetic study.
Akrami A; Hsieh F; Almon V; Bruenner BA; James C; Wong P
J Pharm Biomed Anal; 2011 Jul; 55(5):1104-10. PubMed ID: 21481559
[TBL] [Abstract][Full Text] [Related]
36. Quantitation of the ataxia-telangiectasia-mutated and Rad3-related inhibitor elimusertib (BAY-1895344) in human plasma using LC-MS/MS.
Kiesel BF; Parise RA; Krishnamurthy A; Gore S; Beumer JH
Biomed Chromatogr; 2022 Nov; 36(11):e5455. PubMed ID: 35876841
[TBL] [Abstract][Full Text] [Related]
37. A rapid, LC-MS/MS assay for quantification of piperacillin and tazobactam in human plasma and pleural fluid; application to a clinical pharmacokinetic study.
Popowicz ND; O'Halloran SJ; Fitzgerald D; Lee YCG; Joyce DA
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Apr; 1081-1082():58-66. PubMed ID: 29505960
[TBL] [Abstract][Full Text] [Related]
38. Determination of MS-275, a novel histone deacetylase inhibitor, in human plasma by liquid chromatography-electrospray mass spectrometry.
Hwang K; Acharya MR; Sausville EA; Zhai S; Woo EW; Venitz J; Figg WD; Sparreboom A
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 May; 804(2):289-94. PubMed ID: 15081922
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry.
Haouala A; Zanolari B; Rochat B; Montemurro M; Zaman K; Duchosal MA; Ris HB; Leyvraz S; Widmer N; Decosterd LA
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(22):1982-96. PubMed ID: 19505856
[TBL] [Abstract][Full Text] [Related]
40. Development and validation of an LC-MS/MS method for quantitative determination of GS87, a novel antineoplastic agent, in mouse plasma.
Kunati SR; Yang S; Wald D; Xu Y
J Pharm Biomed Anal; 2018 May; 153():145-151. PubMed ID: 29482106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
